According to data from the London School of Hygiene & Tropical Medicine, a dozen Covid-19 vaccine projects have entered clinical trials. One of them believes he knows the New york times, could have taken the advantage in the race launched to stop the pandemic which has killed more than 210,000 people worldwide.
Scientists at the Jenner Institute at the University of Oxford in the United Kingdom have designed a vaccine that not only has shown promising results in rhesus macaque monkeys, but is starting to be tested on humans in the part of a large clinical trial.
Last month, the Rockies Laboratory at the National Institutes of Health in Montana exposed primates to the virus and inoculated six of them with single doses of the Oxford vaccine. Twenty-eight days later, the six “vaccinated” were in good health, while their fellows had all developed the disease.
It is too early to declare victory: Dr. Vincent Munster, who carried out the test, specifies that the scientists are still analyzing the results, which will be shared next week with other researchers, before being submitted to a committee review of reading.
Above all, if the rhesus macaque is the “closest” species of Sapiens sapiens, as Munster recalls, immunity in monkeys does not guarantee that the vaccine will provide the same degree of protection to humans.
The University of Oxford says in any case that it will soon be fixed. His Jenner Institute was able to plan tests of this vaccine involving more than 6,000 people by the end of May, while competing projects have at best only a few hundred participants. Like the vaccine from the Chinese laboratory Sinovac Biotech, which is also effective in rhesus macaques, but whose trial has yet to be carried out on 144 people.
If the Oxford vaccine is safe and works, the first million doses of their vaccine could be available by September, says The New York Times. However, clinical trials generally take at least six months.
The Jenner Institute got ahead by carrying out similar tests that have proven harmless to humans, including one last year, already against a coronavirus, explains the daily but also by obtaining the green light from the British authorities in a very short time.